    <style>
       .border-content {
            border: 1px solid #000001;
            padding: 2px;
            margin-bottom: 5px;
        }
    </style>
    <section class="border-content">
        <p><strong>WARNING: RISK OF SERIOUS HARM OR DEATH WITH INTRAVENOUS ADMINISTRATION; SUBLOCADE RISK EVALUATION AND MITIGATION STRATEGY</strong></p>
    <ul>
        <li><strong>Serious harm or death could result if administered intravenously. SUBLOCADE forms a solid mass upon contact with body fluids and may cause occlusion, local tissue damage, and thrombo-embolic events, including life threatening pulmonary emobli, if administered intravenously.</strong></li>
    </ul>
    </section>
    <section>
        <p><strong>IMPORTANT SAFETY INFORMATION</strong></p>
        <p>Prescription use of this product is limited under the Drug Addiction Treatment Act.</p>
    </section>
    <section>
        <p><strong>CONTRAINDICATIONS</strong></p>
        <p>SUBLOCADE should not be administered to patients who have been shown to be hypersensitive to buprenorphine or any component of the ATRIGEL<sup>Â®</sup> delivery system</p>
        <p>Please click here to full <a href="https://www.sublocade.com/Content/pdf/prescribing-information.pdf" target="_blank">Prescribing Information</a> including BOXED WARNING</p>
    </section>